Yarrow Bioscience Inc (YARW NASDAQ) stock market data APIs
$29.156
0.77(2.6%)
as of September 18, 2026
Try our APIs with
free plan!
Yarrow Bioscience Inc Financial Data Overview
Price chart is built with
Anychart
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.
Prev. Close
29.156
Open
29.922
High
31.7811
Low
29.0926
52 wk Range
8.2508-44.276
Market Cap
78 197 K
Shares Outstanding
2 670 K
EPS
-2.14
Dividends (Yield)
0
Beta
2.068
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Yarrow Bioscience Inc data using free add-ons & libraries
Get Yarrow Bioscience Inc Fundamental Data
Yarrow Bioscience Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Yarrow Bioscience Inc News
New
Yarrow Bioscience prices $150M public offering of common stock at $26 per share
Yarrow Bioscience (YARW [https://seekingalpha.com/symbol/YARW]) announced the pricing of an underwritten public offering [https://seekingalpha.com/pr/20648019-yarrow-bioscience-announces-pricing-of-15...
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
NEW HAVEN, Conn., September 11, 2026--(BUSINESS WIRE)--Yarrow Bioscience, Inc. ("Yarrow" or the "Company") (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing transformative t...
VYNE Therapeutics GAAP EPS of -$2.14 misses by $1.92
* VYNE Therapeutics press release [https://seekingalpha.com/pr/20617851-yarrow-bioscience-reports-second-quarter-2026-financial-results-and-provides-business-update] (YARW [https://seekingalpha.com/...
Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE
(RTTNews) - The following biotech stocks reached a 52-week high on August 3, 2026, driven by key catalysts such as upcoming quarterly reports or the initiation of clinical trials. AngioDynamics Inc. ...
Get Yarrow Bioscience Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
